Revvity | Nuværende Forpligtelser



Current Liabilities Lave om Dato
Adcock Ingram Holdings ZAR 2.53B 85.57M 2024-06
Agilent USD 1.87B 26M 2025-01
Align Technology USD 2.04B 25.59M 2024-12
Bio Techne USD 161.26M 19.13M 2024-12
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Bruker USD 1.28B 37.5M 2024-12
Celltrion KRW 3.03T 141.48B 2024-09
Charles River Laboratories USD 994.1M 18.12M 2024-12
Cspc Pharmaceutical CNY 10.44B 252.73M 2024-06
Danaher USD 6.8B 541M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Dianthus Therapeutics USD 15.71M 5.68M 2024-09
Ecofibre AUD 20.78M 803K 2024-06
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
Hologic USD 1B 34.8M 2024-12
Illumina USD 1.55B 572M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 272.46M 81.21M 2024-06
Laboratory Of America USD 3.33B 81.8M 2024-12
Malin Corporation EUR 500K 500K 2024-06
Medical Developments International AUD 9.55M 1.61M 2024-06
Mettler Toledo International USD 1.17B 16.77M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Patterson Companies USD 1.31B 39.02M 2025-01
Pharma Mar EUR 82.69M 6.75M 2024-12
Qiagen NV USD 543.63M 584.94M 2024-12
Quest Diagnostics USD 2.17B 77M 2024-12
Quidel USD 998.8M 28.5M 2024-12
Repligen USD 108.37M 65.94M 2024-09
Revvity USD 653.1M 34.84M 2024-12
Sartorius EUR 977M 116.3M 2024-09
Sino Biopharmaceutical CNY 21.95B 657.56M 2024-06
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Tilray USD 278.52M 15.02M 2024-11
Waters USD 789.76M 26.28M 2024-12
Zz Pientze Pharmaceu 3.1B 569.38M 2024-09



Revvity Nuværende Forpligtelser - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.